Shandong Lukang Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of December 2024: 0.01%

Shandong Lukang Pharmaceutical Co Ltd (600789) has an Asset Resilience Ratio of 0.01% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.22 Million

≈ $178.52K USD Cash + Short-term Investments

Total Assets

CN¥9.10 Billion

≈ $1.33 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how Shandong Lukang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Shandong Lukang Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shandong Lukang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shandong Lukang Pharmaceutical Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.22 Million	0.01%
Total Liquid Assets	CN¥1.22 Million	0.01%

Asset Resilience Insights

Limited Liquidity: Shandong Lukang Pharmaceutical Co Ltd maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Lukang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Lukang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Almirall S.A. MC:ALM	Drug Manufacturers - Specialty & Generic	0.01%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
Zhejiang Tianyu Pharmaceutical Co Ltd SHE:300702	Drug Manufacturers - Specialty & Generic	0.00%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.15%

Annual Asset Resilience Ratio for Shandong Lukang Pharmaceutical Co Ltd (2009–2024)

The table below shows the annual Asset Resilience Ratio data for Shandong Lukang Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.01%	CN¥1.22 Million ≈ $178.52K	CN¥9.10 Billion ≈ $1.33 Billion	0.00pp
2023-12-31	0.01%	CN¥1.19 Million ≈ $174.28K	CN¥8.80 Billion ≈ $1.29 Billion	0.00pp
2022-12-31	0.01%	CN¥1.26 Million ≈ $184.38K	CN¥8.73 Billion ≈ $1.28 Billion	0.00pp
2021-12-31	0.02%	CN¥1.21 Million ≈ $176.77K	CN¥7.79 Billion ≈ $1.14 Billion	+0.00pp
2020-12-31	0.02%	CN¥1.09 Million ≈ $160.23K	CN¥7.27 Billion ≈ $1.06 Billion	0.00pp
2019-12-31	0.02%	CN¥1.15 Million ≈ $168.43K	CN¥7.09 Billion ≈ $1.04 Billion	+0.00pp
2018-12-31	0.02%	CN¥1.05 Million ≈ $153.36K	CN¥6.57 Billion ≈ $961.02 Million	-0.01pp
2017-12-31	0.03%	CN¥1.53 Million ≈ $223.89K	CN¥5.20 Billion ≈ $761.20 Million	-0.02pp
2016-12-31	0.05%	CN¥1.96 Million ≈ $286.22K	CN¥4.18 Billion ≈ $611.38 Million	-0.02pp
2015-12-31	0.06%	CN¥2.57 Million ≈ $376.51K	CN¥4.02 Billion ≈ $588.00 Million	+0.02pp
2014-12-31	0.04%	CN¥1.77 Million ≈ $258.86K	CN¥4.08 Billion ≈ $597.75 Million	-0.19pp
2013-12-31	0.23%	CN¥9.50 Million ≈ $1.39 Million	CN¥4.07 Billion ≈ $596.27 Million	+0.20pp
2012-12-31	0.03%	CN¥1.13 Million ≈ $164.92K	CN¥3.99 Billion ≈ $583.16 Million	+0.00pp
2011-12-31	0.03%	CN¥956.94K ≈ $140.03K	CN¥3.48 Billion ≈ $509.42 Million	-0.02pp
2010-12-31	0.05%	CN¥1.47 Million ≈ $215.25K	CN¥3.03 Billion ≈ $442.67 Million	+0.00pp
2009-12-31	0.05%	CN¥1.19 Million ≈ $173.84K	CN¥2.48 Billion ≈ $362.67 Million	--

pp = percentage points

About Shandong Lukang Pharmaceutical Co Ltd

SHG:600789 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.06 Billion

CN¥7.27 Billion CNY

Market Cap Rank

#8757 Global

#2159 in China

Share Price

CN¥6.96

Change (1 day)

+0.87%

52-Week Range

CN¥6.81 - CN¥10.91

All Time High

CN¥16.22